Andrew D. Bowser
New ASH guideline: VTE prophylaxis after major surgery
December 12, 2019
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
November 22, 2019
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy, benefits of sustained virologic response, preemptive therapy in donor-positive organ transplant.
Ask about vaping in patients with respiratory symptoms, CDC says
November 20, 2019
New CDC recommendations intended to help HCPs pinpoint and manage vaping-associated lung injuries as seasonal respiratory infections trend upward.
Readmission for COPD exacerbation upped in-hospital mortality risk
October 25, 2019
NEW ORLEANS – Reduction of readmission rates has potential to improve health and economic outcomes, according to researchers.
Vitamin C–based regimens in sepsis plausible, need more data, expert says
October 22, 2019
NEW ORLEANS – Results from the randomized, phase 3 VICTAS study, anticipated in the coming months, may shed light on the clinical role of this adjunctive strategy.
In-hospital flu shot reduced readmissions in pneumonia patients
October 22, 2019
NEW ORLEANS – In-hospital influenza vaccination linked to lower readmission rates in database analysis.
Early palliative care consult decreases in-hospital mortality
October 21, 2019
NEW ORLEANS – More discharges to hospice, and more health care surrogates chosen, when palliative care consultation occurs within 24 hours of ICU admission
Machine learning–derived risk score predicts heart failure risk in diabetes patients
September 22, 2019
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
Post-TAVR anticoagulation alone fails to cut stroke risk in AFib
August 19, 2019
By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.
Systolic, diastolic BP each tied to adverse CV outcomes
July 17, 2019
Diastolic hypertension can’t be ignored, investigator says, though systolic ultimately has a larger impact.